Abstract
This study has found that the Maltose binding protein Aβ42 fusion protein (MBP-Aβ42) forms soluble oligomers while the shorter MBP-Aβ16 fusion and control MBP did not. MBP-Aβ42, but neither MBP-Aβ16 nor control MBP, was toxic in a dose-dependent manner in both yeast and primary cortical neuronal cells. This study demonstrates the potential utility of MBP-Aβ42 as a reagent for drug screening assays in yeast and neuronal cell cultures and as a candidate for further Aβ42 characterization.
Crown Copyright © 2011. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Amyloid beta-Peptides / chemistry*
-
Amyloid beta-Peptides / genetics
-
Amyloid beta-Peptides / toxicity*
-
Animals
-
Apoptosis
-
Cerebral Cortex / cytology
-
Maltose-Binding Proteins / chemistry
-
Maltose-Binding Proteins / genetics
-
Maltose-Binding Proteins / toxicity
-
Mice
-
Neurons / drug effects*
-
Peptide Fragments / chemistry*
-
Peptide Fragments / genetics
-
Peptide Fragments / toxicity*
-
Protein Multimerization
-
Recombinant Fusion Proteins / chemistry*
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / toxicity*
-
Saccharomyces cerevisiae / drug effects
-
Solubility
Substances
-
Amyloid beta-Peptides
-
Maltose-Binding Proteins
-
Peptide Fragments
-
Recombinant Fusion Proteins
-
amyloid beta-protein (1-42)